Hypertrophic Cardiomyopathy in the Elderly: A Case Identified With Genetic Screening

Overview

Journal J Investig Med High Impact Case Rep

Specialty General Medicine

Date 2022 Jul 2

PMID 35778879

Authors

Gaspar Del Rio-Pertuz

Pooja Sethi

Deephak Swaminath

Erwin Argueta-Sosa

Affiliations

Soon will be listed here.

Abstract

Hypertrophic cardiomyopathy (HCM) is a hereditary disease with an autosomal dominant pattern of inheritance, that is caused by a mutation in one of several sarcomere genes that encodes components of the contractile system of the heart. Hypertrophic cardiomyopathy has been described as a disease that is more heavily diagnosed in the second decade of life, that may present with abnormal syncopal episodes or sudden cardiac death. However, with a better understanding of the genetic changes that occur in HCM and with improved imaging techniques, there has now been an increased recognition of a late-onset disease that can occur in the elderly population. We report a case of a 73-year-old woman who was found to have HCM after various clinical events took place.

References

Tower-Rader A, Mohananey D, To A, Lever H, Popovic Z, Desai M . Prognostic Value of Global Longitudinal Strain in Hypertrophic Cardiomyopathy: A Systematic Review of Existing Literature. JACC Cardiovasc Imaging. 2018; 12(10):1930-1942. DOI: 10.1016/j.jcmg.2018.07.016. View

Lee D, Rakowski H . Hypertrophic Cardiomyopathy in Elderly Individuals: Is It a Rose by Another Name?. J Am Heart Assoc. 2021; 10(3):e020204. PMC: 7955421. DOI: 10.1161/JAHA.120.020204. View

Maron B, Maron M, Semsarian C . Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am Coll Cardiol. 2012; 60(8):705-15. DOI: 10.1016/j.jacc.2012.02.068. View

Wolf C . Hypertrophic cardiomyopathy: genetics and clinical perspectives. Cardiovasc Diagn Ther. 2019; 9(Suppl 2):S388-S415. PMC: 6837941. DOI: 10.21037/cdt.2019.02.01. View

Iung B, Baron G, Butchart E, Delahaye F, Gohlke-Barwolf C, Levang O . A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003; 24(13):1231-43. DOI: 10.1016/s0195-668x(03)00201-x. View

Alashi A, Smedira N, Popovic Z, Fava A, Thamilarasan M, Kapadia S . Characteristics and Outcomes of Elderly Patients With Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2021; 10(3):e018527. PMC: 7955450. DOI: 10.1161/JAHA.120.018527. View

Liu D, Hu K, Nordbeck P, Ertl G, Stork S, Weidemann F . Longitudinal strain bull's eye plot patterns in patients with cardiomyopathy and concentric left ventricular hypertrophy. Eur J Med Res. 2016; 21(1):21. PMC: 4862218. DOI: 10.1186/s40001-016-0216-y. View

Semsarian C, Ingles J, Maron M, Maron B . New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015; 65(12):1249-1254. DOI: 10.1016/j.jacc.2015.01.019. View

Maron B, Gardin J, Flack J, Gidding S, Kurosaki T, Bild D . Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995; 92(4):785-9. DOI: 10.1161/01.cir.92.4.785. View

10.

Maron B . Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002; 287(10):1308-20. DOI: 10.1001/jama.287.10.1308. View

11.

Klues H, Schiffers A, Maron B . Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol. 1995; 26(7):1699-708. DOI: 10.1016/0735-1097(95)00390-8. View

12.

Tuohy C, Kaul S, Song H, Nazer B, Heitner S . Hypertrophic cardiomyopathy: the future of treatment. Eur J Heart Fail. 2020; 22(2):228-240. DOI: 10.1002/ejhf.1715. View

13.

Maron B, Desai M, Nishimura R, Spirito P, Rakowski H, Towbin J . Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022; 79(4):390-414. DOI: 10.1016/j.jacc.2021.11.021. View

14.

Ommen S, Mital S, Burke M, Day S, Deswal A, Elliott P . 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020; 76(25):3022-3055. DOI: 10.1016/j.jacc.2020.08.044. View

15.

Nkomo V, Gardin J, Skelton T, Gottdiener J, Scott C, Enriquez-Sarano M . Burden of valvular heart diseases: a population-based study. Lancet. 2006; 368(9540):1005-11. DOI: 10.1016/S0140-6736(06)69208-8. View

16.

Lever H, Karam R, Currie P, Healy B . Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape. Circulation. 1989; 79(3):580-9. DOI: 10.1161/01.cir.79.3.580. View

17.

Maron B, Casey S, Olivotto I, Sherrid M, Semsarian C, Autore C . Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators. Circ Arrhythm Electrophysiol. 2018; 11(4):e005820. DOI: 10.1161/CIRCEP.117.005820. View

18.

Maron M, Wells S . Myocardial Strain in Hypertrophic Cardiomyopathy: A Force Worth Pursuing?. JACC Cardiovasc Imaging. 2019; 12(10):1943-1945. DOI: 10.1016/j.jcmg.2018.09.026. View